-25.4%
MRNA vs CG
-23.4%
-2.0%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +0.5% | -5.4% | -5.1% |
| 7D | -20.9% | -5.8% | -15.1% | -18.2% |
| 30D | -13.3% | +6.0% | -19.2% | -16.1% |
| 3M | +212.6% | -19.9% | +232.5% | +254.5% |
| 6M | +309.0% | -16.3% | +325.3% | +348.7% |
| YTD | +567.3% | -33.1% | +600.4% | +713.1% |
| 1Y | +689.7% | -23.4% | +713.1% | +800.4% |
| 3Y | +157.4% | +33.1% | +124.4% | +113.5% |
| All | -25.4% | -23.4% | -2.0% | -27.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CG.
Daily Out/Under-Performance
Portfolio return minus CG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling